Literature DB >> 24789954

Prevalence and prognosis of unclassifiable interstitial lung disease.

Lauren Troy1, Ian Glaspole, Nicole Goh, Chris Zappala, Peter Hopkins, Margaret Wilsher, Yuben Moodley, Tamera Corte.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24789954     DOI： 10.1183/09031936.00003414

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

1.  Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore.

Authors:  Gin Tsen Chai; Teck Choon Tan; Yeong Shyan Lee; Gregory Jl Kaw; Khoon Leong Chuah; Yi Jing Lim; John Arputhan Abisheganaden; Bernard Yh Thong
Journal:  Singapore Med J       Date:  2019-07-11       Impact factor: 1.858

2.  A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective.

Authors:  Christopher J Ryerson; Tamera J Corte; Joyce S Lee; Luca Richeldi; Simon L F Walsh; Jeffrey L Myers; Jürgen Behr; Vincent Cottin; Sonye K Danoff; Kevin R Flaherty; David J Lederer; David A Lynch; Fernando J Martinez; Ganesh Raghu; William D Travis; Zarir Udwadia; Athol U Wells; Harold R Collard
Journal:  Am J Respir Crit Care Med       Date:  2017-11-15       Impact factor: 21.405

3.  Using Bronchoscopic Lung Cryobiopsy and a Genomic Classifier in the Multidisciplinary Diagnosis of Diffuse Interstitial Lung Diseases.

Authors:  Fayez Kheir; Ala Alkhatib; Gerald J Berry; Philip Daroca; Lisa Diethelm; Reinaldo Rampolla; Shigeki Saito; David L Smith; David Weill; Marjorie Bateman; Ramsy Abdelghani; Joseph A Lasky
Journal:  Chest       Date:  2020-05-25       Impact factor: 9.410

4.  Unclassifiable interstitial lung disease: an unresolved diagnostic dilemma.

Authors:  Stefanie C Leung; Andrew M Churg; Jonathon A Leipsic; Robert D Levy; Pearce G Wilcox; Christopher J Ryerson
Journal:  Respirol Case Rep       Date:  2015-06-09

Review 5.  Current concepts and dilemmas in idiopathic interstitial pneumonias.

Authors:  Jay H Ryu; Teng Moua; Natalya Azadeh; Misbah Baqir; Eunhee S Yi
Journal:  F1000Res       Date:  2016-11-10

6.  Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebo-controlled phase II trial.

Authors:  Toby M Maher; Tamera J Corte; Aryeh Fischer; Michael Kreuter; David J Lederer; Maria Molina-Molina; Judit Axmann; Klaus-Uwe Kirchgaessler; Vincent Cottin
Journal:  BMJ Open Respir Res       Date:  2018-09-04

7.  Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.

Authors:  J H Fisher; M Kolb; M Algamdi; J Morisset; K A Johannson; S Shapera; P Wilcox; T To; M Sadatsafavi; H Manganas; N Khalil; N Hambly; A J Halayko; A S Gershon; C D Fell; G Cox; C J Ryerson
Journal:  BMC Pulm Med       Date:  2019-11-27       Impact factor: 3.317

Review 8.  Diagnosing interstitial lung disease by multidisciplinary discussion: A review.

Authors:  Laura M Glenn; Lauren K Troy; Tamera J Corte
Journal:  Front Med (Lausanne)       Date:  2022-09-21

Review 9.  Differential diagnoses of fibrosing lung diseases.

Authors:  Carolyn Horst; Bahareh Gholipour; Arjun Nair; Joseph Jacob
Journal:  BJR Open       Date:  2019-06-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.